Replies to post #142941 on Biotech Values

[DewDiligence]

FDA grants priority review for Promacta in HCV:

http://finance.yahoo.com/news/ligand-partner-glaxosmithkline-announces-priority-111500097.html

Inasmuch as the NDA was submitted on 5/30/12, the PDUFA date should be on or around 11/30/12.